REVANESSE® REVISE™ is a highly crosslinked hyaluronic acid dermal filler designed for precise correction of deep and challenging aesthetic concerns. It’s particularly effective for revising asymmetry, correcting scars, and addressing deep-set wrinkles and volume loss, especially in tough-to-treat areas.
- Designed for structural correction and deep dermal support
- 25 mg/mL hyaluronic acid concentration
- Enhanced with 0.3% lidocaine for greater injection comfort
- Monophasic gel with smooth consistency for even distribution
- Provides high lifting capacity with minimal migration
- Ideal for deep folds, acne scars, and facial asymmetry
- FDA-cleared and manufactured in North America
REVANESSE® REVISE™ – Unique Technology
REVANESSE® REVISE™ is powered by Thixofix® crosslinking technology, which ensures optimal gel elasticity, longevity, and integration with natural tissue. It allows high moldability while maintaining structure.
- Thixofix® technology provides balance between viscosity and flexibility
- Enables easy shaping post-injection
- Ultra-pure HA: low endotoxin and protein levels reduce inflammation risk
- Maintains cohesiveness, minimizing clumping or migration
- Homogeneous texture ensures precision in revision work
REVANESSE® REVISE™ – Indications
REVANESSE® REVISE™ is indicated for patients who require advanced correction for volume irregularities, deep-set wrinkles, or contour asymmetries, particularly where prior treatments may have failed.
- Treatment areas include:
- Midface depressions
- Nasolabial folds
- Chin and jawline asymmetries
- Deep acne scars or post-traumatic indentations
- Volume deficits from aging or prior aesthetic procedures
- Not intended for:
- Lips or areas requiring soft, superficial correction
- Periorbital or superficial dermal use
REVANESSE® REVISE™ – Ingredients
REVANESSE® REVISE™ contains high-concentration, non-animal sourced hyaluronic acid formulated with a local anesthetic to reduce patient discomfort.
- Hyaluronic acid: 25 mg/mL
- Lidocaine hydrochloride: 0.3%
- Phosphate buffer solution: stabilizes pH and viscosity
- No animal or human proteins; fully biocompatible and biodegradable
REVANESSE® REVISE™ – How To Use
REVANESSE® REVISE™ is injected into the deep dermis or subcutaneous layer using either a needle or cannula. It is suitable for trained aesthetic medical professionals seeking refined control in structural correction.
- Recommended tools:
- 27G needle or blunt cannula
- Injection depth: Deep dermis or subcutis
- Volume per syringe: 1.0 mL
- Technique: Linear threading, fanning, or bolus depending on defect
- Treatment sessions: Usually 1–2, spaced 4–6 weeks apart
- Results can last up to 12 months
REVANESSE® REVISE™ – Side Effects and Precautions
REVANESSE® REVISE™ has a strong safety profile with low rates of adverse events due to its ultrapure formulation. However, some injection-related side effects may still occur.
- Common side effects:
- Swelling, redness, bruising
- Tenderness at injection site
- Less common:
- Nodules, unevenness, discoloration
- Prolonged edema in sensitive patients
- Rare:
- Vascular occlusion (requires immediate action)
- Hypersensitivity reactions
- Not recommended for:
- Pregnant or breastfeeding women
- Patients with autoimmune disorders or active skin infections
REVANESSE® REVISE™ – Clinical Studies and Real-World Outcomes
REVANESSE® REVISE™ has been evaluated in both clinical settings and real-world applications, with strong satisfaction scores from physicians for its performance in scar revision and structural lifting.
- High lift capacity and tissue support in structural applications
- Smooth gel integration = natural correction without lumpiness
- Studies show persistent results for up to 12 months
- Widely used in revision work post-filler complications
- Trusted by practitioners for precise facial balancing
REVANESSE® REVISE™ – Manufacturer Information
REVANESSE® REVISE™ is manufactured by Prollenium Medical Technologies Inc., a Canadian company known for its innovative HA-based injectables. The brand adheres to ISO-certified standards and FDA-cleared protocols.
- Manufacturer: Prollenium Medical Technologies Inc.
- Country: Canada
- Brand family: Revanesse® (includes Versa™, Lips™, Shape™, Ultra™, etc.)
- All products are FDA-cleared and Health Canada approved
- Produced under sterile and GMP conditions
REVANESSE® REVISE™ – FAQ
What makes REVISE™ different from other fillers?
It is designed for reconstructive and structural purposes, not superficial filling. Its high viscosity and moldability make it ideal for correcting deep asymmetries and scars.
Is it suitable for lips or fine lines?
No, it is too dense and structured for superficial or soft-tissue areas like lips.
How long do results last?
Results can last up to 12 months, depending on injection depth and patient metabolism.
Is it reversible?
Yes, as a hyaluronic acid filler, it can be dissolved with hyaluronidase in case of overcorrection or complications.
Can it be used after complications from other fillers?
Yes, it’s commonly used in revision cases, especially where previous products left irregularities or insufficient volume.
